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Ryanodolchannels (DHPR) is known to trigger ryanodine receptor (RyR)-mediated Ca2+-
release from sarcoplasmic reticulum (SR). The mechanism that terminates SR Ca2+ release is still unknown.
Previous reports showed evidence of Ca2+-entry independent inhibition of Ca2+ sparks by DHPR in
cardiomyocytes. A peptide from the DHPR loop II-III (PepA) was reported to modulate isolated RyRs. We
found that PepA induced voltage-dependent “ﬂicker block” and transition to substates of fully-activated
cardiac RyRs in planar bilayers. Substates had less voltage-dependence than block and did not represent
occupancy of a ryanoid site. However, ryanoids stabilized PepA-induced events while PepA increased RyR2
afﬁnity for ryanodol, which suggests cooperative interactions. Ryanodol stabilized Imperatoxin A (IpTxA)
binding but when IpTxA bound ﬁrst, it prevented ryanodol binding. Moreover, IpTxA and PepA excluded each
other from their sites. This suggests that IpTxA generates a vestibular gate (either sterically or allosterically)
that prevents access to the peptides and ryanodol binding sites. Inactivating gate moieties (“ball peptides”)
from K+ and Na+ channels (ShakerB and KIFMK, respectively) induced well resolved slow block and substates,
which were sensitive to ryanoids and IpTxA and allowed, by comparison, better understanding of PepA
action. The RyR2 appears to interact with PepA or ball peptides through a two-step mechanism, reminiscent
of the inactivation of voltage-gated channels, which includes binding to outer (substates) and inner (block)
vestibular regions in the channel conduction pathway. Our results open the possibility that “ball peptide-
like” moieties in RyR2-interacting proteins could modulate SR Ca2+ release in cells.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIn striated muscle, ryanodine receptor channels (RyR) located at
the sarcoplasmic reticulum (SR) calcium stores are the main pathway
for intracellular Ca2+ release upon physiological or pharmacological
stimulation [1–3].
Functional studies of gating of RyR channel molecules require their
isolation from cells [4,5]. The response to pharmacological and
physiological agonists of these isolated RyRs, studied in lipid bilayers
or puriﬁed SR vesicles, is similar to that of RyR-mediated Ca2+
signaling in cells [3,6,7]. However, the non-inactivating behavior and
Ca2+ dependence of RyR in bilayers and microsomes cannot explain
why the calcium release process in cells terminates while cytosolic
and lumenal Ca2+ still remain at levels that sufﬁce to keep isolated RyR
channels fully active [3,8].
In skeletal muscle, L-type Ca2+ channels (DHPR) activate RyR1-
mediated SR Ca2+ release through physical interactions [1–3,9].
Differently, in heart, DHPR-mediatedCa2+ entry is required for effectivel rights reserved.activation of cardiac RyR2 during excitation contraction coupling [1–
3,9,10]. Under resting conditions, however, DHPR-RyR physical inter-
actions seem to occur in both cell types, which completely (in skeletal
ﬁbers) or partially (in cardiac myocytes) prevent Ca2+ sparks [9–14].
Various peptides from DHPR cytosolic domains modulate the function
of isolated RyRs [15–28]. Interestingly, a peptide domain from the II-III
loop of the skeletal DHPR (α subunit) named Peptide Amodulates both
cardiac and skeletal RyRs [25–28]. The action of Peptide A on RyRs is
complex and may include activation, inhibition and the production of
substates [22,25–28].
The aim of this work was to further characterize the action of
Peptide A on fully-activated cardiac RyR2. Caffeine activated-RyR2s
were selected as they aremore appropriate to study the action of pore-
blockers or substate-inducing agents and they can better mimic the
gating status of RyRs upon fast activation by Ca2+ in cells [29,30]. We
also determined if Peptide A-induced subconductance states represent
the interaction of this peptide with binding sites in the RyR2 for two
well known conductance modiﬁers, ryanodine and Imperatoxin A.
There is functional homology between the structure of the
cytosolic conduction pathway in RyR2 and those in voltage-gated K+
and Na+ channels [31]. Therefore, we compare the action of Peptide A
to that of peptides homolog to cytosolic regions (ball peptides) of
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physiological inactivation of their respective channels (Shaker B [32]
and KIFMK [33], respectively). Although KIFMK is simpler and smaller
than Peptide A and Shaker B, we found that the three peptides acted as
voltage-dependent blockers of RyR2 and they all induced substates.
The action of peptides was profoundly affected by ryanoids and by
Imperatoxin A. Some of these results have been presented in
preliminary form [34,35].
2. Materials and methods
2.1. Drugs and chemicals
CaCl2 standard for calibration was from Word Precision Instru-
ments Inc. (Sarasota, FL). Phospholipids were obtained from Avanti
(Alabaster, AL). Ryanodine was from Calbiochem (San Diego, CA).
Ryanodol was obtained from hydrolyzed ryanodine as previously
described [36]. All other drugs and chemicals were either from Sigma-
Aldrich or were reagent grade.
2.2. Peptides
Imperatoxin A (IpTxA; GDCLPHLKRCKADNDCCGKKCKRRGT-
NAEKRCR) was from Alomone Labs (Jerusalem, Israel). Peptide A
(TSAQKAKAEERKRRKMSRGL) from the skeletal DHPR II-III loop,
Shaker B (MAAVAVLYVLGKKRQHRKKQ), and Na+ channel inactivating
peptide (acetyl-KIFMK-amide) were custom-synthesized and puriﬁed
by Alpha Diagnostics Inc. (San Antonio, TX).
2.3. Sarcoplasmic reticulum microsomes
All procedures with animals were designed to minimize pain and
suffering and conformed to the guidelines of the National Institutes of
Health. The committee on the Use and Care of Laboratory Animals
(LACUC) of Southern Illinois University School of Medicine reviewed
and approved the protocols for animal use. Sarcoplasmic reticulum
membrane fractions were obtained from rabbit skeletal muscle and
dog heart ventricle using cellular subfractionation methods based on
Saito et al., 1984 [37] and Chamberlain et al., 1983 [4]. After isolation,
the bulk of SR preparations was aliquoted into 300 μl cryovials and
kept in liquid nitrogen (better and safer long-term storage). Every
month, the content of a few cryovials are aliquoted (15 μl each) and
stored at −80 °C for easy access. For experiments, aliquots were
quickly thawed in water, kept in ice and used within 3–5 h.
2.4. Bilayer technique
Reconstitution of RyR2 in planar lipid bilayers, was done as
previously described [38]. Brieﬂy, planar lipid bilayers were formed on
80 to 100 μm-diameter circular holes in teﬂon septa, separating two
1.3 ml compartments. The trans compartment was ﬁlled with HEPES-
Ca2+ solution containing HEPES 250 mM and Ca(OH)2 53 mM, pH 7.4.
The trans compartment was clamped at 0 mV using an Axopatch 200B
patch-clamp ampliﬁer (Axon Instruments, Foster City, CA). The cis
compartment (ground) was ﬁlled with HEPES-Tris solution containing
HEPES 250mM and TrisOH 118mM, pH 7.4. Bilayers of a 5:4:1 mixture
of bovine brain phosphatidylethanolamine, phosphatidylserine and
phosphatidylcholine (45–50 mg/ml in decane) were painted onto the
holes of teﬂon septa from the cis side. A mixture of BAPTA and
dibromo-BAPTAwas used to buffer free [Ca2+] on the cytosolic surface
of the channel ([Ca2+]cyt) [38]. As previously done [38], RyR channels
were identiﬁed by current amplitudes (∼3.5 pA at 0 mV), slope
conductance (∼100 pS, and reversal potential of approximately
−45 mV, trans–cis) and response to diagnostic ligands (e.g., ryanodine,
Ca2+, ATP, caffeine and Ruthenium Red). RyR channel currents are
depicted as positive (upward deﬂections of the current) in ﬁgures andreﬂect cation ﬂux from the trans (luminal) to the cis (cytosolic)
compartment. Membrane voltages always represent the difference
trans–cis compartments (in mV).
2.5. Single-channel analysis
Channel currents were ﬁrst ﬁltered through the Axopatch 200B
low-pass Bessel ﬁlter at 2 kHz, digitized at 20 kHz with an analog to
digital converter (Digidata 1320, Axon Instruments) and stored on
DVD. Recordings were analyzed using pClamp9 software (Axon
Instruments). Analysis with this program included open times, closed
times and open probabilities (Po), which were determined by half-
amplitude threshold analysis of single-channel recordings as done
before [38].
Recordings were digitally ﬁltered at 500 Hz (experiments at
Vm≥0 mV) or 400 Hz (experiments at Vmb0 mV or all Vm in presence
of ryanodine) in order to estimate the probabilities of substates using
two different methods:
1) Manual analysis of the traces. Frame by frame analysis (100 ms/
frame) was performed using pClamp9 on each 4-min recording.
In most of our recordings, we were able to distinguish different
levels of current that included the baseline (blocked channels),
full openings and 1–3 main substate levels. Events, at different
levels of current lasting more than 3 ms, were manually selected.
The parameters (mean amplitude and duration) of each event
were collected and averaged. The probability of substate
occurrence, Psubstate, was estimated from the ratio: time spent
in substate/total recording time. Pblock was estimated as the
fraction of time spent in baseline current (block state).
2) Current-amplitude distributions. All-points current-amplitude
histograms (band width=0.01 pA) were obtained from each 4-
min recording. Histograms were normalized so that total histo-
gram area=1. In most of our experiments, we were able to detect
peaks (components) corresponding to the baseline, full opening
and 1–3 substate levels. Each component was ﬁtted with a
Gaussian function using the Levenberg–Marquardt method.
When the ﬁtting is good, the ﬁtted area of each component can
be used as an estimation of its probability. This was the case when
we analyzed the recordings shown in Figs. 2D, 3 and 7 where the
current-amplitude distribution analysis and the frame by frame
analysis provided statistically identical results.
In the presence of ryanodine, the probabilities of Shaker B and
KIFMK-induced substates were determined using frame by frame
analysis and they were only signiﬁcant at Vm≤0. In the absence of
ryanodine, KIFMK-induced substates are rare and do not signiﬁcantly
affect the current-amplitude distribution. In the presence of ryano-
dine at Vmb0, the small signal-to-noise ratio precluded the unequi-
vocal resolution of all individual components from the amplitude
distribution histograms. In these cases, the Psubstate were only
estimated using frame by frame analysis.
In the presence of Peptide A, the probability of ryanodol-induced
substates was also estimated using frame by frame analysis. The
length of ryanodol-induced events (ranging 0.1–1 s) allowed excellent
resolution despite the occurrence of Peptide A-induced block and
substates. Similarly, the probabilities of IpTxA-induced substates
(ranging 0.1–1 s) in the presence of Peptide A, Shaker B or KIFMK
were determined using frame by frame analysis.
For experiments shown in Fig. 2A (Peptide A), we estimated Po and
mean open time by half-amplitude thresholds but the Psubstate could
not be estimated due to the abundance of unresolved ﬂickering events.
2.6. Statistical analysis
Data are shown as means±S.E.M. of n measurements. Statistical
comparisons between groups were performed with Student's t-test of
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cant at Pb0.05.
3. Results
In this work, we studied the action of Peptide A added to the
cytosolic surface of cardiac RyR2 reconstituted into planar lipid
bilayers. Peptide A has been shown to have various effects on partially
active skeletal channels [25] but its fast kinetics complicated the
interpretation. Consequently, we determined the action of Peptide A
on fully-activated channels and compared it to that of ball peptides
(which allow better time resolution due to their slower kinetics). A set
of studies were also carried out on skeletal muscle RyR1 or with RyR2
in the absence of caffeinewith comparable results (results not shown).
3.1. Differential effects of peptide a, shaker b and kimfk on RyR2
channels
RyR2 channels were activated by Ca2+ and caffeine to lock the
channels in high Po mode [39]. Under these conditions, most channels
were fully open (PoN0.9) and displayed a small number of gating
events (few short closures), which allowed good characterization of
peptide-induced blocking events.
Peptide A, Shaker B or KIFMK added to the cytosolic chamber
decreased Po of RyR2 in a voltage-dependent manner (Fig. 1). We
analyzed the voltage dependence of peptide block using a modiﬁed
version of the equation derived by Woodhull [40] for block of a one-
site, two-barrier channel model which has been shown to be
applicable to RyR channels [41]: Prelative=1/ [1+([Peptide] /KPep)exp
(dzVmF /RT)] where F, R, and T have their usual meanings, Prelative is
the ratio of open probabilities (presence of peptide/absence of
peptide) measured at each voltage, and KPep is the peptide
concentration at which block is half-maximal at 0 mV. dz is the
“equivalent valence” of the blocker [40], inﬂuenced by z (blocker
valence) and d (fraction of the membrane potential acting at the site),
a term that includes binding site location within the membrane ﬁeld,
Ca2+-peptide interactions in the pore and the possibility of multi-site
peptide block.
From the data shown in Fig. 1, we estimated that Peptide A (z=6)
had a KPep=4.30 ±0.71 μM and d=0.72 ±0.11. Shaker B (z=7) had
similar KPep=6.74 ±0.94 μM and d=0.82±0.06. For KIFMK (z=2) we
estimated a larger KPep=6.1±0.3 mM and d=1.2±0.3. These resultsFig. 1. Peptides block RyR2 in a voltage-dependent manner. Mean open probability (Po)
of RyR2 channels as a function of holding voltage (Vm) ranging from −30 mV to +40 mV
(trans–cis). RyR2 channels were fully activated by the combined action of Ca2+ (10 μM)
and caffeine (5 mM) in their cytosolic (cis) surface. Lumenal (trans) Ca2+ (50 mM) was
the current carrier. Po's are mean values from n=15 (control; ﬁlled circles), 4 (Peptide A,
open squares), 6 (Shaker B, open diamonds) and 6 (KIFMK; open triangles). Values are
shown as mean±SEM. Lines represent ﬁts of the Woodhull equation to experimental
data (see Results).suggest that Shaker B and KIFMK block RyRs with similar afﬁnity to
their action on K+ channels and Na+ channels, respectively [33,42].
As shown in Fig. 2A, Peptide A-induced events at 0mVweremostly
fast ﬂicker block (mean duration 0.81±0.07 ms; n=4), which were not
well resolved due to the ﬁltering of data at 500–1000 Hz. For Shaker B,
block events were longer (Fig. 2B), usually from ∼100 ms to seconds
(mean block time at 0 mV=1.18±0.21 s; n=6). As Shown in Fig. 2C,
KIFMK-induced block events had intermediate duration (compared to
Peptide A and Shaker B). The mean block time at 0 mVwas 5.3±0.3 ms
(n=6). Thus, Peptide A is amuch faster blocker than Shaker B or KIFMK.
Channel transitions to subconductance states (substates) are a rare
occurrence for RyR2 when Ca2+ is used as current carrier. Here, it was
noticeable that all peptides induced substates, although with variable
efﬁcacy. Peptide A induced substates lasting a few milliseconds with
low frequency but they were difﬁcult to distinguish from the noise
produced by the unresolved ﬂicker block events (Fig. 2A). In the
presence of the slower blocker Shaker B (2 μM), we detected low
frequency of substates (Fig. 2B, upper right panel). At higher
concentrations (20 μM), Shaker B blocked the channels ∼85% of the
time (0mV) and half of the openings were to substates of ∼50 and 70%
of the full conductance (Fig. 3). Additionally, we detected transitions to
substates of ∼32% of the full conductance but their frequency was too
low to produce a signiﬁcant component in the amplitude distribution
histograms. There is no strong correlation between induction of
substates and the blocking kinetics of the peptides. Indeed, the
peptides with fastest and slowest block kinetics (Peptide A and Shaker
B) were both more effective in inducing substates than KIFMK. Frame
by frame analysis of the recordings was required to evidence that
KIFMK (500 μM) also increased frequency of substates 37±9 times
(from 0.9±0.3 to 22.1±4.4 events/min, n=5 paired observations).
KIFMK-induced substate levels were ∼27.3±0.3, 48.6±0.7 and 72.3
±0.5% of the full conductance. Notice, however, that the probability of
substate events was extremely low and was not discernible from the
noise in the current-amplitude distribution histograms.
The results suggest that, although different peptide moieties can
induce substates and block, the RyR2 conduction pore would
kinetically discriminate between peptides (probably because of size,
charges and hydrophobicity).
3.2. Ryanodine-modiﬁed RyR2 are more sensitive to the action of
peptides
Ryanodine binds speciﬁcally to RyRs in a virtually irreversible
manner, i.e. dissociation has an apparent t1/2 of 8–25 h [43,44].
Ryanodine locks the channels open in a modiﬁed state with slope
conductance of ∼40% that of full openings [3,45]. Studies with
ryanoids indicated that, similar to peptides, they bind to a site that
senses the electric ﬁeld [46,47]. If peptide-induced substates result
from their reversible interaction with the “ryanoid site”, then we
should not observe these substates in ryanodine-modiﬁed channels
(the “ryanoid site” would be occupied by ryanodine).
In the presence of ryanodine, channels are locked open; closures
are brief and extremely rare (Fig. 2A–D, lower left panels). Paired
studies of the action of Peptide A before and after addition of ryanodine
are shown in Fig. 2A. Clearly, Peptide A became a more efﬁcacious
blocker after the channels were modiﬁed by ryanodine (Fig. 2A, upper
right versus lower right panels). In the presence of Peptide A, the
fraction of time spent in the full open state by the control versus the
ryanodine-modiﬁed channels decreased from 0.44±0.02 to 0.10±0.03
at 0mV; from 0.65±0.01 to 0.29±0.05 at 10mV and from 0.86±0.08 to
0.53±0.04 at 20 mV (n=4). This decrease in the probability of full
openings (Po) reﬂects an increase in both block and intermediate
conductance states induced by Peptide A, as shown in the amplitude
histograms (Fig. 2A, upper right versus lower right panels). In
ryanodine-modiﬁed channels most events were brief and the signal-
to-noise ratio was reduced due to the decreased conductance.
Fig. 2. Ryanodine modiﬁes the action of peptides and of Imperatoxin A. The ﬁgure shows single-channel recordings of single RyR2 channels activated with Ca2+/caffeine. Openings are shown as upward deﬂections (o = full open; b = baseline).
The frequency-current amplitude histograms obtained from 4min single-channel recordings are shown next to each trace. The ﬁgure shows the effects of (A) 5 μMPeptide A, (B) 2 μM Shaker B, (C) 500 μMKIFMK and (D) 20 nM Imperatoxin A.
In all cases four panels are shown. Upper panels. Representative traces recorded at the indicated voltages in the absence of ryanodine under control conditions (upper left panels) and after addition of 5 μM Peptide A, 2 μM Shaker B, 500 μM
KIFMK or 20 nM Imperatoxin A (upper right panels in A, B, C and D, respectively). Lower panels. Single RyR2 channel recordings after modiﬁcation by ryanodine (2 μM). r represents full openings to the ryanodine-modiﬁed state. Traces are
shown under control conditions (lower left panels) and after addition of Peptide A, Shaker B, KIFMK or Imperatoxin A (lower right panels in A, B, C and D, respectively).
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Fig. 3. High doses of Shaker B induce three distinct levels of subconductance. (A) RyR2
recordings of a Ca2+/caffeine-activated channel at Vm=+10 mV in the presence of 20 μM
Shaker B. s1, s2 and s3 indicate the conductance of the different substates. (B) Amplitude
histograms and ﬁts of RyR2 channels exposed to 20 μM Shaker B.
2473M. Porta et al. / Biochimica et Biophysica Acta 1778 (2008) 2469–2479Consequently, we were unable to quantitatively resolve between
Peptide A-induced block events and substates.
The effects of Shaker B on fully-activated RyR2were similar to those
found with Peptide A. As shown, in Fig. 2B, upper panels, in the
presence of Shaker B (2 μM), only one substate was signiﬁcant at 0 mV
(Psub=0.08±0.004) but was less frequent at more positive voltages. In
the ryanodine-modiﬁed channels, transitions to three distinct Shaker
B-induced substates signiﬁcantly increased (∼40% of total openings;
Fig. 2B, lower panels). They had 30±1%, 49±2% and 74±1% the
amplitude of the full openings of the ryanodine-modiﬁed channel
(n=4). These proportions are equivalent to those found for substates
induced by 10-fold higher doses of Shaker B in non-modiﬁed channels
(Fig. 3).
KIFMK also induced abundant substates in the ryanodine-
modiﬁed RyR2 (Fig. 2C, lower panels). Again, we observed three
substates of 31±1%, 51±1% and 75±1% of the amplitude of the full
openings of the ryanodine-modiﬁed channel (n=8). Similar to Shaker
B, these proportions are equivalent to those found for KIFMK in the
absence of ryanodine (27±1%, 52±1% and 74±2%, n=8). With
ryanodine, the increase in the probability of KIFMK-induced substates
is much more dramatic than the change in full block events (i.e.,
events that decrease channel current to baseline levels). Notice that
although the frequency of block events did not increase, the block
dwell time increased by 316±62% (from 9.2±2.2 ms to 29.9±10.5 ms;
n=6). Frame by frame analysis revealed the presence of KIFMK-
induced substates of three distinct subconductance levels. However,
one of them (of ∼52% the ryanodine-modiﬁed conductance) was
highly predominant and represented the most signiﬁcant component
in the histograms from 4 min recordings shown in Fig. 2C, lower rightpanel. The other two had lower frequency and in some cases, they
could not be detected in the current-amplitude distribution
histograms.
In the presence of ryanodine, when we changed the holding
potential from 0 mV to +20 mV, the probability of Shaker B-induced
block decreased by 89% while the probability of Shaker B-induced
substates decreased only by 48%. Similar results were observed with
KIFMK. A change in voltage from 0 to +20 mV decreased Pblock by 83%
and Psubstate by 61%. The results indicate that peptide-induced block is
more sensitive to voltage than the formation of peptide-induced
substates, again suggesting that peptides produce block and substates
by binding to different sites. Our results also suggest that block and
substates are not speciﬁc to Peptide A and that the formation of
peptide-induced substates does not represent peptide binding to the
ryanoid site.
3.3. Ryanodine-modiﬁed RyR2 are more sensitive to the action of
imperatoxin A
The dual action of peptides (substates and block) complicates the
interpretation of results. However, Imperatoxin A (IpTxA) which has
structural homology with Peptide A induces the formation of
substates but does not block the channel [48]. Therefore, if the
formation of IpTxA-induced and peptide-induced substates result
from the binding of these agents to a common site in the RyR, IpTxA
could be a relevant tool to study the block and substate-inducing
effects of peptides as two separate phenomena.
As shown in Fig. 2D (upper left panels), 20 nM IpTxA induced the
formation of substates (∼1/3 the full channel conductance) in a
voltage-dependent manner. Upon addition of ryanodine, IpTxA
remained effective to induce “sub-substates”. Fig. 2D shows that
the probability of IpTxA-induced substate (PIpTxA) was much higher
in the ryanodine-modiﬁed RyRs than that observed in the non-
modiﬁed channels (PIpTxA increased from 0.51±0.03 to 0.91±0.02 at
0 mV; from 0.29±0.02 to 0.92±0.03 at +10 mV; from 0.09±0.02 to
0.85±0.03 at +20 mV and from 0.04±0.01 to 0.59±0.03 at 30 mV,
n=5). Data collected at +10 mV also show that the increase in PIpTxA
correlates with a large increase in the substates’ mean duration
(from 1.8±0.6 to 27.7±10 s; n=5) and a modest but signiﬁcant
increase in the probability of the transition full open → PIpTxA (from
10.3±1.7 to 21.9±3.6 events min−1; n=5). Thus, ryanodine also
increases the afﬁnity for IpTxA in the RyR2. A similar increase in the
afﬁnity of all substate sites may also explain why peptide-induced
substates have higher probability and are better discernable in the
presence of ryanodine.
3.4. Imperatoxin A excludes peptides from the substate site
As both IpTxA- and peptide-induced substates increase in the
presence of ryanodine, we tested whether these agents interact with
each other. Fig. 4A and C (upper panels) show recordings of Ca2+/
caffeine-activated RyR2 exposed to 50 nM IpTxA. Channels oscillate
between full openings and the IpTxA substate. Closures are very rare
during the full openings and are virtually zero during the IpTxA
substate. Addition of 20 μM Peptide A (Fig. 4A, lower panels)
induced marked ﬂicker block during the full openings but not during
IpTxA substates. A similar observation was made with 40 μM Shaker
B (Fig. 4C, lower panels). During full openings, Shaker B produced
long block events but no events were observed during IpTxA-
induced substates. However, as shown in Fig. 4B and D, the
probability of ﬁnding the channel in the IpTxA-induced substate
decreased upon addition of Peptide A (from 0.78±0.13 to 0.28±0.11;
n=4) or Shaker B (from 0.87±0.01 to 0.30±0.03; n=5). The results
indicate that when IpTxA is bound to the RyR2, it prevents the block
and substate-inducing actions of peptides. This suggests that IpTxA
and Shaker B/Peptide A compete for a common binding site.
Fig. 4.Mutual exclusion of Imperatoxin versus Peptide A or Shaker B. (A) Single-channel recordings of RyR2 with Ca2+/caffeine and IpTxA (50 nM) at Vm=+10mV. Traces under control
conditions (top) and after adding 20 μM Peptide A (bottom). (B) Probability (Psubstate; black bars) and dwell time (grey bars) of imperatoxin-induced substates before and after
addition of Peptide A. ⁎pb0.05, n=5 paired observations. (C) RyR2 recordings in presence of Ca2+/caffeine and IpTxA (50 nM); Vm=+10 mV. Traces are shown in the absence (control;
conditions (top) and presence of 40 μM Shaker B (bottom). (D) Probability (Psubstate; black bars) and dwell time (grey bars) of imperatoxin-induced substates before and after addition
of 40 μM Shaker B. ⁎pb 0.05, n=4 paired observations.
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substates during the IpTxA-induced events. This again suggests that
IpTxA binding prevents access to the substate-inducing site. Unlike
Peptide A and Shaker B, KIFMK was able to block the IpTxA-modiﬁed
channel (Fig. 5) suggesting that the IpTxA binding site and the blocking
site might be different. Notice that in the recordings shown in Fig. 5A,
block events during IpTxA-induced substates are much longer than
during channel full openings (Fig. 5B). The apparent dissociation
constant of KIFMK from RyR2 (1/dwell time) decreased from 166 s−1
during full openings to 3.1 s−1 during IpTxA substates. However,
KIFMK-induced block events were much less abundant during IpTxA
substates (Fig. 5C), indicating a much larger decrease in the rate of
association. As a consequence, the probability of blocking the channels
was signiﬁcantly lower during IpTxA-induced substates than during
full openings (Fig. 5D).
IpTxA also counteracted the action of peptides on the ryanodine-
modiﬁed RyR2. During IpTxA-ryanodine “sub-substates”, Peptide A
and Shaker B were ineffective and KIFMK only induced some block
events (results not shown).
In summary, the results shown in this section indicate that IpTxA
binding impedes the access of the large peptides (Peptide A/Shaker
B) to the “substates” and “block” sites. The smaller peptide KIFMK
can still access the block site suggesting that IpTxA does not
compete for its occupancy. However, IpTxA increased the energy
barrier for KIFMK binding and then stabilizing the peptide at the
block site. These results also suggest that the Peptide A “block site”may be located deeper than the “substates site” in the RyR2 region
that senses the electric ﬁeld.
3.5. Cooperative interaction of ryanoids with Peptides and Imperatoxin A
The possibility that Peptide A and IpTxA affect the afﬁnity of RyR2 for
ryanoids was also tested using ryanodol. As ryanodol reversibly binds to
the ryanodine-binding site [46], RyR2 reversibly ﬂuctuated between the
full opening and the ryanodol-modiﬁed state (Fig. 6A, left panels).
Ryanodol action is voltage-dependent [47]. When we changed voltage
from 0 to +20mV the probability of ryanodol modiﬁcation decreased by
52±11% (n=6). Fig. 6A (right panels) shows that Peptide A was more
efﬁcient to block the channel and induce substates during ryanodol-
modiﬁed events versus full openings. This is similar to the results
obtained with and without ryanodine (Fig. 2A). The additional informa-
tion provided by Fig. 6B is that the probability of ryanodol-induced
modiﬁcation increased upon addition of Peptide A (from 0.58±0.04 to
0.76±0.05). This correlates with increased dwell times for ryanodol-
modiﬁed states (Fig. 6B). This suggests that Peptide A stabilizes ryanodol
bound to RyR2 by decreasing its rate of dissociation.
A similar increase in the probability of ryanodol modiﬁcation was
evident with IpTxA. As shown in Fig. 7A (left panels) and B (upper
panels), under control conditions the channel is switching between
the full opening (Probability ∼80%) and the ryanodol state (Probability
∼20%). After the addition of IpTxA, we observed full openings and
three states (from higher to lower conductance): ryanodol (R), IpTxA
Fig. 5. Imperatoxin modiﬁes kinetics of RyR2 block by KIFMK. (A) Single-channel recordings of RyR2 with Ca2+/caffeine and IpTxA (50 nM) at Vm=+10 mV. Traces under control
conditions (left) and after addition of 500 μMKIFMK (right) are shown. (B) Dwell times of KIFMK block. (C) Number of block events and (D) Probability of block (Pblock). Parameters of
KIFMK block were estimated during segments of full openings (black bars) and during imperatoxin-induced substates (grey bars). ⁎pb0.05, n=5 paired observations.
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binding to RyR2 (R and R+i) increased (∼40%). This was true at all
voltages tested but+30 mV, where IpTxA and ryanodol bindings have
low probability (Fig. 7B and C). Notice, however, that in all cases the
probability of R (ryanodol alone) decreased dramatically. Thus, when
ryanodol binds, IpTxA follows, stabilizing the channel in R+i (Fig. 7C).
These results, as well as those in Fig. 2 (increase in the actions of
peptides or IpTxA with ryanodine), suggest that peptides/IpTxA
cooperatively interact with ryanoids stabilizing each other's associa-
tion to RyR2.
Additional analysis of data suggests that initial binding of
ryanodol or IpTxA had opposite effects on the probability of
reaching R+i. Fig. 7D shows estimations (from 40 min of recordings
at +10 mV) of the probability of full openings, R, i, and R+i
substates. The data indicates that the channels spend more time in
the IpTxA alone state (∼41% of the time) than in i+R state (30%).
This seems to be in contrast with the idea of a more stable R+i
state. However, it can be explained by the existence of a preferential
order in the sequence by which both agents (ryanodol and IpTxA)
bind to RyR2. The arrows show RyR2 transitions from one state to
another. From the number of events, we can determine that
channels residing in R substates (98 events) are much more likely
to change to the R+i substate (93 times) than back to the full open
state (5 times). In contrast, channels in the IpTxA substate (873
events) frequently changed back to the open state (867 times) but
only rarely to the R+i substate (6 times). Relative rate of transition
(number of transitions A→B /probability A) for R→R+i (4650) nearly
doubled that for Open→i (2780). More important, the rate of the
transition R+i→R (218) was much lower than that of i→Open
(2114). This again indicates stabilization of IpTxA binding during the
R substates. Contrarily, the rate for Open→R (130) is much higher
than that of i→R+i (14.6), suggesting that when IpTxA binds ﬁrst, it
prevents ryanodol binding. Thus, there is a preferred sequence ofbinding Open→R→R+i (93% of the cases). This asymmetry is much
less evident for the transitions R+i→i (144) vs. R+i→R (218), which
suggests that R and i dissociation from RyR2 does not have a
preferred sequence.
4. Discussion
We found that Peptide A could interact with sites in the RyR2
conduction pathway to induce substates and block. This action was
enhanced by ryanoids. Concomitantly, the afﬁnity of the ryanoid site
for its ligands increased, suggesting that Peptide A and ryanoids
cooperatively interact.
The action of Peptide A was prevented by Imperatoxin A (IpTxA) a
compound that induced one single type of substate and did not induce
RyR2 channel block. IpTxA also stabilized ryanodol bound to the RyR2.
However, when IpTxA binds ﬁrst, it prevents the access of ryanodol to
its binding site.
The voltage-gated channel ball peptides (Shaker B and KIFMK) also
induced voltage-dependent block and substates that were sensitive to
ryanoids and IpTxA.
4.1. Peptide A occludes the RyR2 pore
Previous studies have shown various effects of Peptide A on
skeletal RyR1 [16–18,23,25–28]. However, skeletal RyR1 channels
have variable levels of activity, voltage dependence and modal gating
and are usually reconstituted as multichannels [38]. In our hands, this
inherent complexity of RyR1 behavior precluded good quantization of
the action of Peptide A [34].
Cardiac RyR2 channels can be frequently reconstituted as single
channels and are much more homogeneous [38]. Therefore, we tested
the action of Peptide A, Shaker B andKIFMKon fullyactive RyR2, locked
in “high Po” mode by caffeine [39]. Under these conditions, Peptide A
Fig. 6. Peptide A increases the probability of the Ryanodol substate. (A) Single-channel recordings of a RyR2 in the presence of Ryanodol (10 μM) before and after addition of 5 μM
Peptide A (Vm=0 mV). “R” represents openings to the ryanodol-induced subconductance state. The temporarily expanded traces (lower panels) evidence that Peptide A action is
different during full openings vs. ryanodol-induced substates. (B) Probability (Psubstate; black bars) and dwell time (grey bars) of ryanodol-induced substates before and after addition
of Peptide A. ⁎pb0.05, n=5 paired observations.
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conductance (substates). Shaker B and KIFMKhad similar action (block
and substates) but slower kinetics (“slow block”) on RyR2. Thismade it
possible to resolve well deﬁned substate levels of ∼30, 50 and 70% of
the full RyR2 conductance. Peptides and IpTxA had a qualitatively
similar action on RyR2 in the absence of caffeine (results not shown).
Under these conditions, however, quantization of block events cannot
be attained due to the interference by normal events of RyR2
alternating between gating modes characterized by long openings
with abundant rapid closures, inactivity or ﬂickering openings.
4.2. Ryanodine-modiﬁcation may increase the afﬁnity of a vestibular
“substate site” to peptides
Our studies indicated that peptides and IpTxA interact with
“substate site(s)” located in a region that is less sensitive to the
transmembrane electric ﬁeld than the “block site”. These peptide-
induced substates do not represent binding to a ryanoid site.
Ryanodine modiﬁcation dramatically stabilized peptide-and IpTxA-
induced substates. Furthermore, the ratio (amplitude of sublevel/
amplitude full openings) of peptide-or IpTxA-induced substates at
Vm≥0 mV was the same in the presence versus absence of ryanodine
modiﬁcation. This suggests that the effects of ryanodine and IpTxA/
peptides on channel conductance result from two separate and
additive processes.
Ryanodine induces a large conformational change in the RyR
channel molecule [49] and “lock open” the RyR in a modiﬁed state of
conductance [3,45]. Our results suggest that such conformational and/or gating changes increase the afﬁnity of the “substate” site(s) for
peptides.
Substates are a common observation in single-channel studies but
it is still unknown if they represent partial occlusion of a pore,
conformational changes or uncoupling of multipores [50–52].
It is thought that tetrameric K+ channels with identical subunits
have four pores that transition in synchrony from closed to open by
the fast coupled movement of four voltage sensors [51]. It has been
suggested that substates represent the rare occasions where voltage
sensors uncouple [51].
The presence of voltage sensors in RyR has been previously
suggested [53]. If the structural homology detected between RyRs
and voltage-gated channels [31] extends to these gates, our results
would suggest that Peptide A interacts with them. The role of these
sensors on RyR2 function remains unclear, since changes in SR
membrane potential during EC-coupling are unlikely (reviewed in
[2]). However, it is possible that voltage changes at the t-tubule
membrane are sensed by Peptide A (or other moieties) of the DHPR
which, in turn, interact with gates of RyR2.
4.3. Imperatoxin A prevents occupancy of Peptide A and ryanoid sites
Our results would suggest that IpTxA can bind to a vestibular
“substate” site but it cannot reach the “block” site. This could be
related to its larger size (compared to the other peptides tested here)
or to its more rigid structure [54].
Previous reports suggested that IpTxA and Peptide A interfere
with each other's actions on RyR2 [17,18,22,23,54]. Accordingly, we
Fig. 7. Imperatoxin increases the probability of the Ryanodol substate. (A) Single-channel recordings of a ryanodol-modiﬁed RyR2 before and after addition of 10 nM IpTxA (Vm=
+20 mV). “R” represents openings to the ryanodol-induced subconductance state. “i” represents opening to the IpTxA-induced substate during RyR2 full openings. “i +R” represents
opening to the IpTxA-induced substate when the channel is being modiﬁed by ryanodol. (B) Amplitude histograms (grey area) and ﬁts (black lines) at 0, +10, +20 and +30 mV of
ryanodol-modiﬁed RyR2 before (upper panels) and after addition of 10 mM IpTxA (lower panels). (C) Probability (PRyanodol) of ryanodol-induced substates before (open circles) and
after addition of 10 nM IpTxA (ﬁlled circles) as a function of holding voltage. (D) Diagram of states of RyR2 exposed to IpTxA plus ryanodol (40 min recording). The following states
were considered: Full openings (Open), IpTxA-induced substate during full openings (IpTxA), Ryanodol modiﬁcation (RyOH) and IpTxA-induced substate during ryanodol
modiﬁcation (RyOH-IpTxA). State probabilities (P) are given in parenthesis. Arrows represent observed unidirectional transitions from one state to another. Adjacent to each arrow is
the respective absolute number of transitions.
2477M. Porta et al. / Biochimica et Biophysica Acta 1778 (2008) 2469–2479found that IpTxA binding prevents Peptide A (and ball peptides)-
induced substates and peptide-induced block in both control and
ryanodine-modiﬁed channels. During IpTxA-induced substates, the
smaller KIFMK was still able to block the channel, suggesting thatIpTxA does not compete for occupancy of the site. These block
events were much less frequent (suggesting increased activation
energy to access the block site) and had longer dwell times
(indicating increased afﬁnity for occupancy of the site).
2478 M. Porta et al. / Biochimica et Biophysica Acta 1778 (2008) 2469–2479In summary, IpTxA bound to RyR2 would behave as a gate that
(either sterically or allosterically) prevents the entrance of Peptide A /
ball peptides to their substate and block sites.
4.4. Peptide a increases afﬁnity of the RyR2 ryanoid site for its ligands
Another novel observation in this article is that ryanoids and
peptides cooperatively interact. Ryanodol and IpTxA also stabilized
each other's binding to RyR2, i.e., the apparent afﬁnities for their
binding sites are increased. Since IpTxA did not induce block, we were
able to determine that there is a preferential sequence of binding. This
suggests that the ryanoid site, similar to the block site, is sensitive to
the action of IpTxA as a gate.
These results also warn us against a possible pitfall of using
“non-equilibrium” [3H] ryanodine binding [44] to estimate changes
in Po of RyRs exposed to open-pore blockers or agents that induce
substates. Here, open RyR2 (Po ∼0.99) were blocked by Peptide A
or modiﬁed by IpTxA and displayed an increased afﬁnity for
ryanoids. These interactions between Peptide A and ryanoid sites
may explain why Peptide A enhances [3H] ryanodine binding to SR
microsomes [19,26,55] while, at similar levels, it inhibits SR Ca2+
release [26].
4.5. Is there a physiological role for “Peptide A-like” modulation of RyR
channels?
Previous studies in skeletal muscle and heart support the idea that
a mechanism of negative control of RyRs exists in striated muscle that
involves DHPR [9–14], which can even hold ryanodine-modiﬁed RyRs
from releasing Ca2+ in skeletal ﬁbers at rest [56]. The present work and
previous studies show that Peptide A from the DHPR II-III loop could
effectively act as a “ball peptide” for RyR2 [27,28]. Although a
signiﬁcant role of Peptide A during EC-coupling is not apparent in
skeletal ﬁbers [57], it is still possible that other “ball-peptide like”
moieties in DHPR or associate molecules participate of the negative
modulation of RyRs.
Native RyRs studied in heart and muscle cells have a much lower
(up to ∼10,000 times) afﬁnity for IpTxA than that of isolated channels
reconstituted in bilayers [58,59]. Moreover, DHPR peptides do not
affect the magnitude and duration of Ca2+ sparks [13]. These results
suggest that in cells, some moiety restricts the access of IpTxA and
peptides to their binding sites in the RyR2.
In summary, our results and previous reports suggest the
possibility of a role for “ball peptides” in the negative control of
RyR-mediated Ca2+ leak under resting conditions or to terminate
RyR-induced Ca2+release during EC-coupling. However, the putative
moiety responsible for this action in cells still needs to be identiﬁed.
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